Cancer cell membrane-biomimetic and antioxidant-powered nanoplatform for overcoming multidrug resistance in triple-negative breast cancer
Year: 2025
Type: article
Language: en
Topic: Nanoplatforms for cancer theranostics
Authors and affiliations:
raw_author_name: Qi Sun
raw_affiliation_strings: Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, 100069, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China. Electronic address: sunqi77@ccmu.edu.cn
Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China. Electronic address: sunqi77@ccmu.edu.cn
raw_author_name: Xinhao Jin
raw_affiliation_strings: Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, 100069, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
raw_author_name: Yitong Ma
raw_affiliation_strings: Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, 100069, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
raw_author_name: Xi Li
raw_affiliation_strings: Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, 100069, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
raw_author_name: Mengqi Peng
raw_affiliation_strings: Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, 100069, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
raw_author_name: Shamuhaer Yelebolati
raw_affiliation_strings: Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, 100069, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China
raw_author_name: Chunying Cui
raw_affiliation_strings: Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, 100069, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China. Electronic address: ccy@ccmu.edu.cn
Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Beijing, 100069, PR China; Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing, 100069, PR China; Beijing Laboratory of Biomedical Materials, Beijing, PR China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100069, PR China. Electronic address: ccy@ccmu.edu.cn